Metformin During Breast Cancer: Dosing and Supplement Safety
Metformin is being studied in breast cancer clinical trials across hormone receptor-positive, HER2-positive, and triple negative subtypes. This guide reviews trial dosing, key supplement interactions including berberine and curcumin, and the safety monitoring patients need when metformin is part of their care plan.
